Wright Medical expects Q4 sales to hit low-end outlook
This article was originally published in Clinica
Orthopaedics specialist Wright Medical has predicted that its sales in the fourth quarter of 2008 are likely to be nearer the lower end of its outlook. The firm expects profit to be $0.28-0.30 per share and revenue to be $119-122m.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals